While often mild and self-limiting, it causes some users to discontinue therapy or struggle with dose escalation
TB-500, as the active fragment of thymosin beta-4, has been widely adopted in preclinical research as a more practical tool for investigating these repair pathways
According to the Centers for Disease Control and Prevention (CDC), an estimated 4.5 million U.S
If any signs of injection site infection develop (increasing redness, warmth, swelling, or pain), discontinue use and consult a healthcare provider
Purity exceeds 99%, guaranteed
Unlike muscle tissue, these structures dont get the same vascular supply, making recovery much harder and often incomplete without intervention